Gold nanoparticles for radiosensitizing and imaging of cancer cells
Creators
- 1. Medical Physics Department, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz (Iran, Islamic Republic of)
- 2. Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz (Iran, Islamic Republic of)
- 3. Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz (Iran, Islamic Republic of)
Description
Highlights: • Gold nanoparticles (AuNPs) can be used for radiosensitizing and imaging of cancer cells. • AuNPs offer a great capacity for increasing photoelectric interactions at lower energy levels. • AuNPs are able to enhance the impacts of radiotherapy by increasing energy deposition in tumor tissues. • AuNPs can be utilized for the simultaneous imaging, radiosensitizing and photothermal/photodynamic therapy of cancer. • AuNPs can be functionalized with different moieties such as targeting and chemotherapy agents. - Abstract: Radiation therapy is a regular treatment modality in cancer therapy. Despite being a beneficial strategy, the radiation doses are limited, in large part because of the occurrence of inadvertent toxicity in the surrounding healthy tissues/organs. Among efforts to minimize the unwanted side effects in normal tissues and sensitize tumor tissues/organs to radiation, utilization of the high atomic number material such as noble metals (e.g., gold, platinum) appears to provide promising outcome as radiation sensitizers. In addition, growing advances in the field of nanomaterials/biomedical sciences have facilitated their applications as radiosensitizers in radiotherapy. Multifunctional nanoparticles (NPs), in particular, gold NPs (AuNPs), which offer a great capacity for increasing photoelectric interactions at lower energy levels, are able to enhance the impacts of radiotherapy by increasing the energy deposition in tumor tissues. Modified AuNPs, with higher mass-energy coefficient in soft tissue at the keV energy range, have reached huge interests in the concurrent radiotherapy of various malignancies. The AuNPs have a great potential to be translated into the clinical applications in various cancer treatments. In this current study, we review the most recent works in the development of gold-based radiosensitizing agents and discuss the utilized approaches for the radiotherapy and articulate their impacts in cancer therapy.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.radphyschem.2018.08.010Additional details
Identifiers
- DOI
- 10.1016/j.radphyschem.2018.08.010;
- PII
- S0969806X17308599;
Publishing Information
- Journal Title
- Radiation Physics and Chemistry (1993)
- Journal Volume
- 152
- Journal Page Range
- p. 137-144
- ISSN
- 0969-806X
- CODEN
- RPCHDM
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 51001969
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE; S38: RADIATION CHEMISTRY, RADIOCHEMISTRY AND NUCLEAR CHEMISTRY;
- Descriptors DEI
- ANIMAL TISSUES; CHEMOTHERAPY; ENERGY ABSORPTION; ENERGY LEVELS; ENERGY LOSSES; GOLD; NANOPARTICLES; NEOPLASMS; PLANT TISSUES; RADIATION DOSES; RADIOSENSITIZERS; RADIOTHERAPY; SIDE EFFECTS
- Descriptors DEC
- ABSORPTION; BODY; DISEASES; DOSES; DRUGS; ELEMENTS; LOSSES; MEDICINE; METALS; NUCLEAR MEDICINE; PARTICLES; RADIOLOGY; RESPONSE MODIFYING FACTORS; SORPTION; THERAPY; TRANSITION ELEMENTS
Optional Information
- Notes
- © 2018 Elsevier Ltd. All rights reserved.